Relay Therapeutics Inc
(RLAY)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 280,119 | 228,559 | 260,069 | 262,720 | 447,646 |
| Marketable Securities | 677,954 | 387,949 | 411,151 | 463,355 | 230,415 |
| Receivables | 403 | 804 | 279 | N/A | 75,000 |
| Other current assets | 6,301 | 4,251 | 4,193 | 8,606 | 7,654 |
| TOTAL | $976,242 | $639,259 | $681,276 | $742,434 | $770,100 |
| Non-Current Assets | |||||
| PPE Net | 6,543 | 6,239 | 6,559 | 5,907 | 6,250 |
| Intangibles | 2,300 | 2,300 | 2,300 | 0 | 0 |
| Other Non-Current Assets | 23,358 | 23,817 | 24,266 | 23,005 | 23,479 |
| TOTAL | $32,201 | $32,356 | $33,125 | $28,912 | $29,729 |
| Total Assets | $1,008,443 | $671,615 | $714,401 | $771,346 | $799,829 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 8,276 | 6,316 | 7,871 | 5,593 | 6,351 |
| Accrued Expenses | 13,557 | 20,102 | 15,405 | 8,867 | 5,760 |
| Other current liabilities | 396 | N/A | N/A | N/A | N/A |
| TOTAL | $24,321 | $28,517 | $25,385 | $16,083 | $13,632 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 248 | 331 | 414 | N/A | N/A |
| Other Non-Current Liabilities | 86,314 | 72,010 | 70,487 | 22,477 | 22,904 |
| TOTAL | $86,314 | $72,010 | $70,487 | $22,477 | $22,904 |
| Total Liabilities | $110,635 | $100,527 | $95,872 | $38,560 | $36,536 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 108,280 | 108,044 | 92,695 | 92,382 | 90,400 |
| Common Shares | 109 | 92 | 92 | 90 | 90 |
| Retained earnings | -768,100 | -700,644 | -639,811 | -446,412 | -404,228 |
| Other shareholders' equity | -1,088 | 10 | -64 | 12 | 64 |
| TOTAL | $897,808 | $571,088 | $618,529 | $732,786 | $763,293 |
| Total Liabilities And Equity | $1,008,443 | $671,615 | $714,401 | $771,346 | $799,829 |